Tyagarajan Seshu

CIK 00019237941 companyNEEDHAM, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001923794

Recent Transactions

20 trades

Award
Candel Therapeutics, Inc.$CADL
Stock Option (Right to Buy)
2026-01-26+154,000→ 154,000 total
Award
Candel Therapeutics, Inc.$CADL
Common Stock
2025-06-25$4.67/sh+5,353→ 90,865 total
Exercise/Conversion
Candel Therapeutics, Inc.$CADL
Common Stock
2025-03-17$1.29/sh+20,000→ 116,790 total
Exercise/Conversion
Candel Therapeutics, Inc.$CADL
Stock Option (Right to Buy)
2025-03-17−20,000→ 70,000 total
Sale
Candel Therapeutics, Inc.$CADL
Common Stock
2025-03-17$8.82/sh−31,278→ 85,512 total
Exercise/Conversion
Candel Therapeutics, Inc.$CADL
Stock Option (Right to Buy)
2025-03-17−20,000→ 70,000 total
Sale
Candel Therapeutics, Inc.$CADL
Common Stock
2025-03-17$8.82/sh−31,278→ 85,512 total
Award
Candel Therapeutics, Inc.$CADL
Stock Option (Right to Buy)
2025-02-12+65,000→ 65,000 total
Sale
Candel Therapeutics, Inc.$CADL
Common Stock
2025-01-15$7.22/sh−14,322→ 96,790 total
Sale
Candel Therapeutics, Inc.$CADL
Common Stock
2025-01-08$8.22/sh−14,545→ 111,112 total
Sale
Candel Therapeutics, Inc.$CADL
Common Stock
2024-11-29$4.56/sh−20,392→ 125,657 total
Sale
Candel Therapeutics, Inc.$CADL
Common Stock
2024-07-17$6.47/sh−14,851→ 146,049 total
Sale
Candel Therapeutics, Inc.$CADL
Common Stock
2024-07-11$5.97/sh−13,330→ 160,900 total
Tax Payment
Candel Therapeutics, Inc.$CADL
Common Stock
2023-11-28$0.90/sh−17,328→ 174,230 total
Award
Candel Therapeutics, Inc.$CADL
Common Stock
2023-11-26+104,516→ 191,558 total
Award
Candel Therapeutics, Inc.$CADL
Stock Option (Right to Buy)
2023-04-28+90,000→ 90,000 total
Purchase
Candel Therapeutics, Inc.$CADL
Common Stock
2022-12-09$1.93/sh+10,358→ 13,358 total
Purchase
Candel Therapeutics, Inc.$CADL
Common Stock
2022-12-08$1.69/sh+3,000→ 3,000 total
Award
Candel Therapeutics, Inc.$CADL
Common Stock
2022-11-28+73,684→ 73,684 total
Award
Candel Therapeutics, Inc.$CADL
Stock Option (Right to Buy)
2022-04-14+120,000→ 120,000 total

Companies

Candel Therapeutics, Inc.
Chief Technology Officer
$CADL

Recent Filings

Address

C/O CANDEL THERAPEUTICS, INC. 117 KENDRICK ST., SUITE 450

NEEDHAM, MA, 02494

View on SEC.gov